Kyowa Kirin competitors and similar companiesClear all

Kyowa Kirin's competitors and similar companies include Takeda Pharmaceutical, Jiangsu Hansoh Pharmaceutical Group, 3sbio and Takeda Oncology.

	Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.	Takeda Pharmaceutical Takeda Pharmaceutical is a biopharmaceutical company.	Jiangsu Hansoh Pharmaceutical Group Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.	3sbio 3sbio (三生制药集团) is a company that develops biopharmaceuticals.	Takeda Oncology Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
Founding Date	Founding Date 2008	Founding Date 1781	Founding Date 1995	Founding Date 1993	Founding Date 1993
Type	Type Public	Type Public	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Tokyo, JP HQ Sydney, AU Shanghai, CN Prague, CZ Tampere, FI Düsseldorf, DE Hong Kong, HK see more	Locations Tokyo, JP HQ The Rocks, AU Linz, AT Wien, AT Lessines, BE Zaventem, BE Sarajevo, BA see more	Locations Lianyungang Shi, CN HQ	Locations Shenyang, CN HQ	Locations Cambridge, US HQ
Employees	Employees 5,9824% increase	Employees 47,3471% increase	Employees 10,5232% decrease	Employees 5,213	Employees 1,7612% increase
Valuation ($)	Valuation ($) 10.6 b	Valuation ($) 50.2 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Employee Rating	Employee Rating N/A	Employee Rating 4	Employee Rating N/A	Employee Rating 3	Employee Rating N/A
Financial
Revenue (est.)	Revenue (est.) ¥398.4b (FY, 2022)	Revenue (est.) ¥4t (FY, 2023)	Revenue (est.) N/A	Revenue (est.) ¥6.9b (FY, 2022)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥78.5b (FY, 2022)	Cost of goods ¥579.7b (FY, 2023)	Cost of goods N/A	Cost of goods ¥821.4m (FY, 2022)	Cost of goods N/A
Gross profit	Gross profit ¥321.6b (FY, 2022)	Gross profit ¥3.5t (FY, 2023)	Gross profit N/A	Gross profit ¥6.1b (FY, 2022)	Gross profit N/A
Net income	Net income ¥53.6b (FY, 2022)	Net income ¥317b (FY, 2023)	Net income N/A	Net income ¥1.9b (FY, 2022)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 57.8m	Total funding raised N/A	Total funding raised $ 15.2m	Total funding raised N/A